Rare diseases
Investigational molecules
Locations
A Study Testing How Well Faricimab Works in Patients with Subretinal Hyperreflective Material Associated with Neovascular Membranes in the Eye
SpainStudy of Faricimab treatment to improve vision in patients with diabetic macular edema using adaptive optics imaging
GermanyStudy on the Effects of Faricimab for Caucasian Patients with Polypoidal Choroidal Vasculopathy
ItalyStudy of Faricimab Treatment Given Every 24 Weeks in Patients with Age-Related Macular Degeneration
FranceFaricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia
FranceStudy on Faricimab and Aflibercept for Patients with Neovascular Age-Related Macular Degeneration Receiving Frequent Aflibercept Treatment
AustriaStudy on Faricimab for Patients with Neovascular Age-Related Macular Degeneration Who Have Not Received Prior Treatment
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
